Elsevier Announces the Launch of Open Access Journal: Colloid and Interface Science Communications

March 10, 2014

AMSTERDAM, March 10, 2014 /PRNewswire/ –

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and solutions, is pleased to announce the launch of open
access journal: Colloid and Interface Science Communications
[http://www.journals.elsevier.com/colloid-and-interface-science-communications ] (COLCOM).

Colloid and Interface Science Communications provides an innovative channel for the
rapid publication of short initial reports on new fundamental concepts, research findings
and topical applications at the forefront of the increasingly interdisciplinary area of
colloid and interface science. Particular emphasis is given to novel experimental
techniques and theoretical/computational methods for advanced studies of interfacial
interactions and design of colloidal materials. Topics covered in the journal include:
nanomaterials, energy production and storage, biotechnologies, nanomedicine, drug
delivery, environmental sustainability, adsorption separations, catalysis,
electrochemistry, food, pharmaceutical, personal care, and cosmetic products.

“Colloidal science, as a classical physico-chemical discipline, laid the foundations
for the revolutionary advent of nanotechnologies in the 21st century. At the same time,
the ground-breaking development of nanoscale materials and devices brings about new
challenges, and the colloidal arena becomes progressively crowded, with a rapidly growing
number of publications. COLCOM will provide the broad scientific community with a
convenient and time-saving resource of urgent reports on novel findings in all areas of
colloid and interface science,” said Editor Alexander V. Neimark, Distinguished Professor,
Department of Chemical and Biochemical Engineering, Rutgers, The State University of New
Jersey.

Rob van Daalen, Publisher at Elsevier, explained, “Colloid and interface science is
increasing its interdisciplinary scope and is a fast-growing area of research. There is a
need to share new findings as fast as possible and globally and we are delighted to be
able to fulfil this need with the launch of Colloid and Interface Science Communications.”

Colloid and Interface Science Communications will publish its first volume in June
2014. This first issue will be presented that 4th International Colloids Conference in
Madrid, Spain, 15-18 June 2014 (http://www.colloidsconference.com).

Elsevier has been providing open access publishing options since 2005. Today,
researchers can choose to publish open access in over 1,600 established peer-reviewed
journals as well as 91 full open access journals and these numbers will continue to grow
rapidly. All of Elsevier’s open access publications have been peer reviewed, ensuring that
the broader community not only reads the latest research but that it is factual, original
and of the highest quality and ethical standards. For more information about Elsevier’s
open access program, visit http://www.elsevier.com/openaccess

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and 25,000 book titles,
including major reference works from Mosby and Saunders. Elsevier’s online solutions
include ScienceDirect [http://www.sciencedirect.com ], Scopus [http://www.scopus.com ],
SciVal [http://info.scival.com ], Reaxys [http://www.elsevier.com/reaxys ], ClinicalKey
[https://www.clinicalkey.com ] and Mosby’s Suite [http://www.confidenceconnected.com ],
which enhance the productivity of science and health professionals, helping research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world leading provider of professional information
solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).